Tyloxapol is a synthetic non-ionic surfactant and polymer classified as an ethylene oxide adduct of p-(1,1,3,3-tetramethylbutyl)phenol, primarily utilized to liquefy and facilitate the removal of thick… Read more
Tyloxapol is a synthetic non-ionic surfactant and polymer classified as an ethylene oxide adduct of p-(1,1,3,3-tetramethylbutyl)phenol, primarily utilized to liquefy and facilitate the removal of thick mucopurulent bronchopulmonary secretions in patients with respiratory conditions such as cystic fibrosis. To ensure the integrity and safety of pharmaceutical products, analytical laboratories rely on high-quality Tyloxapol reference standards for rigorous quality control and method validation. This category encompasses the active pharmaceutical ingredient alongside its identified impurities, potential degradation products, and stable isotope-labelled compounds. These materials are essential for impurity profiling, allowing researchers to accurately detect, identify, and quantify impurities within complex formulations. By utilizing these precise analytical tools, laboratories can maintain compliance with pharmacopeial requirements, support routine release testing, and ensure consistent efficacy in nebulized respiratory treatments.